Proposed Data Collection Submitted for Public Comment and Recommendations, 12900-12901 [2016-05520]

Download as PDF 12900 Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices The meeting will be held in the Board Room located on the sixth floor of the FDIC Building located at 550 17th Street NW., Washington, DC This Board meeting will be Webcast live via the Internet and subsequently made available on-demand approximately one week after the event. Visit https:// fdic.primetime.mediaplatform.com/#!/ channel/1232003497484/ Board+Meetings to view the event. If you need any technical assistance, please visit our Video Help page at: https://www.fdic.gov/video.html. The FDIC will provide attendees with auxiliary aids (e.g., sign language interpretation) required for this meeting. Those attendees needing such assistance should call 703–562–2404 (Voice) or 703–649–4354 (Video Phone) to make necessary arrangements. Requests for further information concerning the meeting may be directed to Mr. Robert E. Feldman, Executive Secretary of the Corporation, at 202– 898–7043. Dated: March 8, 2016. Federal Deposit Insurance Corporation. Valerie Best, Assistant Executive Secretary. [FR Doc. 2016–05609 Filed 3–9–16; 11:15 am] BILLING CODE P FEDERAL RESERVE SYSTEM asabaliauskas on DSK3SPTVN1PROD with NOTICES Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than March 28, 2016. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. James J. Dolan, as trustee of Voting Trust Agreement, Patricia D. Dolan as trustee of Royston Road Trust, all of VerDate Sep<11>2014 17:56 Mar 10, 2016 Jkt 238001 Naples, Florida; Gregory F. Dolan as trustee of JJD 2012 Family Trust, Washington, DC; Emad Murrar, Homer Glen, Illinois, and Alan Reasoner, Round Lake, Illinois; to acquire voting shares of Northwest Bancorporation of Illinois, Inc., and thereby indirectly acquire voting shares of First Bank and Trust Company of Illinois, both in Palatine, Illinois. B. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Margaret M. Brownlee, as trustee of the Margaret March Brownlee Trust, both of Orlando, Florida, and Paula March Romanovsky, as trustee of the Paula March Romanovsky Trust, both of San Francisco, California, all as members of the March family group; to retain voting shares of Bank Management, Inc., and thereby indirectly retain voting shares of FirstBank of Nebraska, both in Wahoo, Nebraska. C. Federal Reserve Bank of Dallas (Robert L. Triplett III, Senior Vice President) 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. Ann Biggs, as trustee of the Gordon Brian Biggs Trust of 2012, the Edward Barrett Biggs Trust of 2012, the Biggs Grandchildren’s Trust, and the Glenn Barrett Biggs Trust of 2012, all of San Antonio, Texas; Steven Mack, Boerne, Texas; and Jack Griggs, Abilene, Texas, collectively a group acting in concert; to acquire voting shares of Southwestern Bancorp, Inc., and thereby indirectly acquire voting shares of Texas Heritage Bank, both in Boerne, Texas. Board of Governors of the Federal Reserve System, March 8, 2016. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2016–05495 Filed 3–10–16; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–16–16TM; Docket No. CDC–2016– 0026] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project entitled ‘‘Prevalence Survey of Healthcare-Associated Infections (HAIs) and Antimicrobial Use in U.S. Nursing Homes.’’ This information collection request will generate data to describe the epidemiology and estimate the burden of HAIs and antimicrobial use in US nursing homes using the prevalence survey method. Results will be used to inform state prevention efforts and federal priority setting for public health initiatives to improve HAI prevention and antimicrobial use. DATES: Written comments must be received on or before May 10, 2016. ADDRESSES: You may submit comments, identified by Docket No. CDC–2016– 0026 by any of the following methods: • Federal eRulemaking Portal: Regulation.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also FOR FURTHER INFORMATION CONTACT: E:\FR\FM\11MRN1.SGM 11MRN1 12901 Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing of HAIs; assessing the nature and extent of antimicrobial use in U.S. healthcare facilities; and assessing the nature and extent of antimicrobial use. Prevalence surveys, in which data are collected in healthcare facilities during a short, specified time period represent an efficient and cost-effective alternative to prospective studies of HAI and antimicrobial use incidence. Given the absence of existing HAI and antimicrobial use data collection mechanisms for nursing homes, prevalence surveys represent a robust method for obtaining the surveillance data required to identify HAIs and antibiotic use practices that should be targeted for more intensive surveillance and to guide and evaluate prevention efforts. The methods for the data collection are based on those used in CDC hospital prevalence surveys and informed by a CDC pilot survey conducted in nine U.S. nursing homes. The survey will be performed by the CDC through the Emerging Infections Program (EIP), a collaboration with CDC and 10 state health departments with experience in HAI surveillance and data collection. Respondents are nursing homes certified by the Centers for Medicare & Medicare Services in EIP states. Nursing home participation is voluntary. Nursing homes will be randomly selected for participation, with a goal in each EIP site of recruiting a total of 20 nursing homes. There will be no anticipated costs to respondents other than their time. Information collection will last approximately one year. and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Prevalence Survey of HealthcareAssociated Infections and Antimicrobial Use in U.S. Nursing Homes—New— National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description Preventing healthcare-associated infections (HAI) and encouraging appropriate use of antimicrobials are priorities of both the U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC). The burden and epidemiology of HAIs and antimicrobial use in U.S. nursing homes is currently unknown. Understanding the scope and magnitude of all types of HAIs in patient populations across the spectrum of U.S. healthcare facilities is essential to the development of effective prevention and control strategies and policies. HAI prevalence and antimicrobial use estimates can be obtained through prevalence surveys in which data are collected in healthcare facilities during a short, specified time period. Essential steps in reducing the occurrence of HAIs and the prevalence of resistant pathogens include estimating the burden, types, and causative organisms ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Average burden per response (in hrs.) Number of responses per respondent Total burden (in hrs.) Form name Director of Nursing, Registered Nurse, Infection Control and Prevention Officer. Registered Nurse .............................. Licensed Practical or Licensed Vocational Nurses. Healthcare Facility Assessment ....... 200 1 45/60 150 Residents by Location Form ............ ........................................................... 200 200 38 38 20/60 20/60 2,533 2,533 Total ........................................... asabaliauskas on DSK3SPTVN1PROD with NOTICES Type of respondents ........................................................... ........................ ........................ ........................ 5,216 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–05520 Filed 3–10–16; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:56 Mar 10, 2016 Jkt 238001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 81, Number 48 (Friday, March 11, 2016)]
[Notices]
[Pages 12900-12901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05520]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-16-16TM; Docket No. CDC-2016-0026]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project entitled ``Prevalence Survey of 
Healthcare-Associated Infections (HAIs) and Antimicrobial Use in U.S. 
Nursing Homes.'' This information collection request will generate data 
to describe the epidemiology and estimate the burden of HAIs and 
antimicrobial use in US nursing homes using the prevalence survey 
method. Results will be used to inform state prevention efforts and 
federal priority setting for public health initiatives to improve HAI 
prevention and antimicrobial use.

DATES: Written comments must be received on or before May 10, 2016.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0026 by any of the following methods:
     Federal eRulemaking Portal: Regulation.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.

Instructions: All submissions received must include the agency name and 
Docket Number. All relevant comments received will be posted without 
change to Regulations.gov, including any personal information provided. 
For access to the docket to read background documents or comments 
received, go to Regulations.gov.

    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also

[[Page 12901]]

requires Federal agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information, including 
each new proposed collection, each proposed extension of existing 
collection of information, and each reinstatement of previously 
approved information collection before submitting the collection to OMB 
for approval. To comply with this requirement, we are publishing this 
notice of a proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Prevalence Survey of Healthcare-Associated Infections and 
Antimicrobial Use in U.S. Nursing Homes--New--National Center for 
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Preventing healthcare-associated infections (HAI) and encouraging 
appropriate use of antimicrobials are priorities of both the U.S. 
Department of Health and Human Services and the Centers for Disease 
Control and Prevention (CDC). The burden and epidemiology of HAIs and 
antimicrobial use in U.S. nursing homes is currently unknown. 
Understanding the scope and magnitude of all types of HAIs in patient 
populations across the spectrum of U.S. healthcare facilities is 
essential to the development of effective prevention and control 
strategies and policies.
    HAI prevalence and antimicrobial use estimates can be obtained 
through prevalence surveys in which data are collected in healthcare 
facilities during a short, specified time period. Essential steps in 
reducing the occurrence of HAIs and the prevalence of resistant 
pathogens include estimating the burden, types, and causative organisms 
of HAIs; assessing the nature and extent of antimicrobial use in U.S. 
healthcare facilities; and assessing the nature and extent of 
antimicrobial use.
    Prevalence surveys, in which data are collected in healthcare 
facilities during a short, specified time period represent an efficient 
and cost-effective alternative to prospective studies of HAI and 
antimicrobial use incidence. Given the absence of existing HAI and 
antimicrobial use data collection mechanisms for nursing homes, 
prevalence surveys represent a robust method for obtaining the 
surveillance data required to identify HAIs and antibiotic use 
practices that should be targeted for more intensive surveillance and 
to guide and evaluate prevention efforts.
    The methods for the data collection are based on those used in CDC 
hospital prevalence surveys and informed by a CDC pilot survey 
conducted in nine U.S. nursing homes. The survey will be performed by 
the CDC through the Emerging Infections Program (EIP), a collaboration 
with CDC and 10 state health departments with experience in HAI 
surveillance and data collection. Respondents are nursing homes 
certified by the Centers for Medicare & Medicare Services in EIP 
states. Nursing home participation is voluntary. Nursing homes will be 
randomly selected for participation, with a goal in each EIP site of 
recruiting a total of 20 nursing homes.
    There will be no anticipated costs to respondents other than their 
time. Information collection will last approximately one year.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs.)       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Director of Nursing,            Healthcare                   200               1           45/60             150
 Registered Nurse, Infection     Facility
 Control and Prevention          Assessment.
 Officer.
Registered Nurse..............  Residents by                 200              38           20/60           2,533
                                 Location Form.
Licensed Practical or Licensed  ................             200              38           20/60           2,533
 Vocational Nurses.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           5,216
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-05520 Filed 3-10-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.